Yıldız Pehlivan, D., H. Yıldız, and G. Kaya. “Dapagliflozin Modulates MicroRNA Expression in Type 2 Diabetes Patients With Diabetic Nephropathy: A Retrospective Study”. European Journal of Therapeutics, vol. 31, no. 1, Feb. 2025, pp. 1-10, doi:10.58600/eurjther2520.